Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: Renal Resistive Index as an Indicator of Lupus Nephritis Severity and Systemic Lupus Activity [NA]
A completed clinical trial investigating whether the renal resistive index can indicate lupus nephritis severity and systemic lupus activity…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies
This clinical trial update reports long-term outcomes in children and adolescents with antiphospholipid antibodies, with a focus on systemic…
-
FDA approval · 2024-12-26FDA Approved: CYCLOPHOSPHAMIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approves Slate Run Pharmaceuticals' original application for CYCLOPHOSPHAMIDE FOR INJECTION, expanding the market for a generic cyclopho…
-
FDA approval · 2024-12-19FDA Approved: CYCLOPHOSPHAMIDE — Original Application (BluePoint Laboratories)
FDA approved BluePoint Laboratories' original ANDA for cyclophosphamide, establishing a generic version of the chemotherapy agent.
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Fatigue in Systemic Lupus Erythematosus
Pamukkale University–sponsored clinical trial investigating fatigue in systemic lupus erythematosus has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases [Phase 1]
Amgen reported completion of a Phase 1 study of MEDI7734 in Type I interferon-mediated autoimmune diseases, including dermatomyositis, polym…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis [Phase 1]
Amgen's Phase 1 study evaluating VIB7734 in multiple autoimmune diseases including systemic lupus erythematosus, cutaneous lupus erythematos…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region
Clinical trial update describing the validation of the Lupus Low Disease Activity State (LLDAS) criteria in the Asia-Pacific region.
-
CLINICAL_TRIALS trial_result · 2024-12-11Clinical Trial Update: Healthy Lifestyle Intervention in Patients with Systemic Lupus Erythematosus: the Living Well with Lupus Study [NA]
This clinical trial update notes the completion of the Living Well with Lupus study, which evaluated a healthy lifestyle intervention in pat…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Rheumatology Diet Study
A rheumatology dietary intervention study sponsored by the University of Central Florida is currently recruiting, listing multiple autoimmun…
-
CLINICAL_TRIALS trial_result · 2024-12-03Clinical Trial Update: Efficacy and Safety of Low-dose IL-2 in Patients With SLE: a Multicenter, Randomised, Placebo-controlled Trial [Phase 2]
Phase 2 multicenter randomized, placebo-controlled trial evaluating low-dose interleukin-2 for systemic lupus erythematosus has completed, r…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Interleukin23 in Systemic Lupus [NA]
A clinical trial is recruiting at Sohag University to evaluate interleukin-23 in systemic lupus erythematosus with interstitial lung disease…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: US Zamto-cel Autoimmune Diseases [Phase 1]
Miltenyi Biomedicine reports a Phase 1 trial of Zamto-cel for autoimmune diseases including lupus nephritis, systemic lupus erythematosus, s…
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: The Impact of Exercise on Hand Function, Daily Activities Performance and Quality of Life of SLE' Patients [NA]
Clinical trial update examining how an exercise program affects hand function, daily activities, and quality of life in patients with System…
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: The Effect of Curcumin on the Clinical Outcome of Pediatric Patients with Active Lupus Nephritis [Phase 2]
Phase 2 pediatric trial evaluating curcumin for active lupus nephritis has completed.
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases [NA]
A clinical trial update shows BRL-301 universal CAR-T cells from Bioray Laboratories enrolling (by invitation) for relapse or refractory aut…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: Safety and Efficacy of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE)
This clinical trial update notes the recruitment of participants to study telitacicept for systemic lupus erythematosus, evaluating its safe…
-
CLINICAL_TRIALS research · 2024-11-19Clinical Trial Update: A Study of SYS6020 Injection in Refractory Active Systemic Lupus Erythematosus [Phase 1]
A Phase 1 clinical trial evaluating SYS6020 Injection in patients with refractory active systemic lupus erythematosus; the study status is n…
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus [Phase 1]
A Phase 1 clinical trial evaluating CD19 UCAR T Cells for efficacy and safety in patients with refractory systemic lupus erythematosus; recr…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Ultrasonic COmparison of Salivary Glands in Autoimmune Diseases (COUGAR)
Clinical trial COUGAR, sponsored by University Hospital, Brest, will evaluate ultrasonic comparisons of salivary glands across autoimmune di…
-
CLINICAL_TRIALS trial_result · 2024-11-07Clinical Trial Update: Immune Cell Subsets in SLE Patients Treated with Telitacicept [Phase 4]
Phase 4 clinical trial evaluating immune cell subsets in systemic lupus erythematosus patients treated with Telitacicept; the study is curre…
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases [Phase 1, Phase 2]
A Phase 1/2 trial evaluating sequential BCMA/CD19 CAR-T cells for relapsed/refractory autoimmune diseases (including systemic lupus erythema…
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE) [Phase 1, Phase 2]
This clinical trial entry notes a Phase 1/2 study evaluating JY231 Injection for active systemic lupus erythematosus (SLE), currently recrui…
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus Erythematosus [Phase 2]
A Phase 2 clinical trial evaluating the safety, tolerability, and pharmacodynamics of KP104 in participants with thrombotic microangiopathy …
-
CLINICAL_TRIALS research · 2024-10-26Clinical Trial Update: Efficacy of Seluang Fish Oil (Rasbora Argyrotaenia) and Synbiotics Supplementation on CD4+CD25+ Foxp3+ T-regulator Cells, IL17/IL-10 Ratio, and Disease Activity in Systemic Lupus Erythematosus Patients [NA]
A clinical trial is evaluating whether Seluang fish oil and synbiotic supplementation affect immune markers and disease activity in systemic…